key: cord-0842970-5bx6bcro authors: Lubinski, Bailey; Jaimes, Javier A.; Whittaker, Gary R. title: Intrinsic furin-mediated cleavability of the spike S1/S2 site from SARS-CoV-2 variant B.1.529 (Omicron) date: 2022-04-22 journal: bioRxiv DOI: 10.1101/2022.04.20.488969 sha: 0c6b53284c6e99d5d022cdfb6e5c281ebe638cc2 doc_id: 842970 cord_uid: 5bx6bcro The ability of SARS-CoV-2 to be primed for viral entry by the host cell protease furin has become one of the most investigated of the numerous transmission and pathogenicity features of the virus. Here, we analyzed the S1/S2 cleavage site (also called “furin cleavage site”) of the spike protein of SARS-CoV-2 B.1.529 (Omicron variant) in vitro, to assess the role of two key mutations (spike gene, N679K and P681H) compared to the ancestral B.1 virus. We observed significantly increased intrinsic cleavability with furin compared to an original B lineage virus (Wuhan-Hu-1) and two variants, B.1.1.7 (Alpha) and B.1.617 (Delta), that subsequently had wide circulation. Increased furin-mediated cleavage was attributed to the N679K mutation, which lies outside the conventional furin binding pocket. Our findings suggest that B.1.529 (Omicron variant) has gained genetic features linked to intrinsic furin cleavability, in line with its evolution within the population as the COVID-19 pandemic has proceeded. The so-called furin cleavage site has become one of the most established transmission and pathogenicity factors of the SARS-CoV-2 spike protein (1), recently reviewed in (2) . A structural loop containing a 682-RRAR-685 amino acid motif was found to be present in the original SARS-CoV-2 isolates (3), with this "furin cleavage site" (FCS) located between the spike receptor-binding (S1) and fusion (S2) domains (S1/S2). An "FCS" has been subsequently found in all circulating variants but has evolved during the course of the pandemic, with the upstream proline (P681) residue being replaced by histidine (H) and arginine (R) in several variants of concern (notably B.1.1.7 -Alpha and B.1.167 -Delta, respectively). This loop/FCS is missing from all other SARS-like viruses (Sarbecoviruses, betacoronavirus lineage B), and is actively de-selected upon adaptation of SARS-CoV-2 to common cell culture systems (e.g., Vero cells); see ref (4) as an example. In late November 2021, a distinct SARS-CoV-2 variant emerged (B.1.529) that had an unusual cluster of mutations, especially in the spike gene (5, 6) . There was an unprecedented and rapidly disseminated series of studies on this variant, which was subsequently named "Omicron" by the World Health Organization. These studies described the quite different infection properties of B.1.529 compared to all other variants that had emerged by that time. In summary, B.1.529 has generally been shown to be less fusogenic and with lowered S1/S2 cleavage than the other variants (7) (8) (9) (10) (11) (12) (13) (14) , especially in comparison to B.1.617.2 (Delta) the predominant variant at the time of B.1.529 emergence. Conversely, it has also been reported that the furin motif in the recombinant Omicron spike ectodomain is more efficient than that in the prototypic spike ectodomain (15) , and many details of the cleavage-activation process of SARS-CoV-2 B.1.529 (Omicron) remain to be resolved. The furin cleavage site for proteins was initially described as a four amino acid pattern P4-R-X-[K/R]-R-P1 (16) , with the cleavage occurring between the P1 and P1' residues, as defined for protease substrates (17) . This motif had become established as a prototype FCS, although the minimal residues for furin cleavage are generally defined as P4-R-X-X-R-P1 (18) . Notably, the sequence context of the four amino acid "FCS" readily modulates cleavability, and subsequent analysis has characterized the furin cleavage motif as a 20 amino acid sequence running from position P14 to P6'-having a "core" region (P6-P2'), along with two flanking solvent accessible regions, P14-P7 and P3'-P6' (19, 20) . The emergence of Omicron was reminiscent of that of the Alpha variant approximately one year earlier; both were notable for a suddenly increased accumulation of mutations, and both have been linked to longterm infection of individuals with persistent SARS-CoV-2 infection (21) . Both Alpha and Omicron contain the same P681H mutation in the FCS (P5 residue), but Omicron contains an additional mutation N679K, which is the P7 residue for furin-mediated cleavage. While within the 20 amino acid sequence comprising a furin cleavage motif, P7 is outside of the core region comprising the established furin binding pocket (19) . N679K introduces an additional basic residue into the FCS, which may result in a more "polybasic" sequence and increase furin-mediated cleavage. Here, we analyze the intrinsic furin-mediated cleavage of the B.1.529 (Omicron) spike "FCS" in comparison to other SARS-CoV-2 variants, and discuss the impact of our observed increased cleavage on the COVID-19 pandemic and virus evolution. Prop: CoV sequences were analyzed using the ProP 1.0 Server hosted at: https://services.healthtech.dtu.dk/service.php?ProP-1.0. PiTou: CoV sequences were analyzed using the PiTou V3 software hosted at: http://www.nuolan.net/reference.html. Fluorogenic peptide cleavage assays were performed as described previously (22) As an initial bioinformatic approach to assess biochemical function, we utilized the PiTou (19) and ProP As expected, both algorithms predicted MERS-CoV to have a relatively low furin cleavage score, with HCoV-HKU1 and HCoV-OC43 showing relatively high furin cleavage scores using both approaches. To directly examine the activity of furin on the SARS-CoV-2 A.23.1 S1/S2 site, we used a biochemical peptide cleavage assay to directly measure furin cleavage activity in vitro (24) . The specific peptide sequences used here are described in Table 1 . Figure 1 : Predicted furin cleavage scores of the S1/S2 region of selected coronavirus spike proteins. We found a noticeable increase in cleavability for Omicron compared to B.1 and all other variants tested, including Delta. With the peptides tested cleavage of Alpha (P681H) was actually decreased compared to B.1, indicating that the P7 K residue has a major impact on furin-mediated cleavage, despite it being outside the proposed "core" furin binding pocket. Trypsin was used as a control (see Appendix). To explore this increased cleavage in more detail, we tested peptides with a P7 lysine residue (K) on the background of either B.1 and Delta FCS sequences (i.e., containing P681 and P681R). In both cases, the P7 K had a notable impact on cleavability, as with Omicron. The peptide with a P7 lysine residue on a B.1 background (P681) had a significantly higher cleavage rate when compared with Omicron, but how this increase in peptide cleavability translates to cleavability in the context of a full spike remains to be seen. Our data show that SARS-CoV-2 B.1.529 (Omicron) has intrinsically high ability to be cleaved by furin at its spike S1/S2 position, despite early studies indicating the contrary, and despite the lowered score predicted by the PiTou FCS cleavage algorithm. In our study, in vitro peptide cleavage data are in line with the ProP FCS prediction tool, and with the data on recombinant S from Ye et al. (15) . Our data further suggest that N679K is a key mutation impacting SARS-CoV-2 spike protein function, especially when combined with additional changes at position 681 (R/H). While our data suggest that these changes are linked to furin processivity, other investigators have recently attributed altered functionality to other proteases, notably cathepsin G (25) . In addition to N679K/P681H is also notable B. Peptides were designed and synthesized to reproduce the S1/S2 site of the SARS-CoV-2 spike protein, examining the effect of introducing a lysine (K) residue at P7 (position 679) along with different established amino acids present at P5 (position 681). Peptides were incubated with furin, fluorescence was monitored for 1 h and the Vmax calculated. Error bars denote the standard error of the mean (SEM) (n=9). Two-tailed unpaired T tests were performed comparing Omicron to each peptide, with significance marked by asterisks. (NS, p = 0.0308; **, p = 0.0085; ****, p < 0.0001) It is noteworthy that mutations upstream of the S1/S2 cleavage motif, including Q675H/R, Q677 H/P as well as N679K have also occurred independently in many SARS-CoV-2 variants (30) and may confer more of a direct impact on furin processing, as they occur in the P9, P11 and P13 positions within the 20 amino acid furin cleavage motif. Despite overall mixed conclusions on Omicron spike cleavage, fusion and infection, our biochemical data support the hypothesis that SARS-CoV-2 is evolving toward increased inherent furin cleavability, with reside 679 (N-K) being a major site of selection. SARS-CoV-2 spike and its adaptable furin cleavage site The emergence of the spike furin cleavage site in SARS-CoV-2 Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis Selection analysis identifies clusters of unusual mutational changes in Omicron lineage BA.1 that likely impact Spike function Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning Omicron adopts a different strategy from Delta and other variants to adapt to host SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity 2022. The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo 2022. The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529 Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins General Aspects of Proteases The biology and therapeutic targeting of the proprotein convertases Computational prediction of furin cleavage sites by a hybrid method and understanding mechanism underlying diseases A 20 Residues Motif Delineates the Furin Cleavage Site and its Physical Properties May Influence Viral Fusion Consulting the Oracle of SARS-CoV-2 Infection A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation Prediction of proprotein convertase cleavage sites Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site Occurrence of a novel cleavage site for cathepsin G adjacent to the polybasic sequence within the proteolytically sensitive activation loop of the SARS-CoV-2 Omicron variant: The amino acid substitution N679K and P681H of the spike protein SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant Omicron spike H655Y mutation is responsible for enhancement of the endosomal entry pathway and reduction of cell surface entry pathways Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant The biological and clinical significance of emerging SARS-CoV-2 variants This work was funded in part by the National Institute of Health research grant R01AI35270 (to GW). We thank the global SARS-CoV-2 sequencing groups for their open and rapid sharing of sequence data and GISAID for providing an effective platform to make these data available, and all members of the Whittaker lab for helpful discussions. As a control, we also tested the ability of trypsin to cleave selected S1/S2 peptides. All variants were cleaved more effectively than for the prototype B.1 virus (Wuhan Hu 1), with B.1.529 (Omicron) showing the most cleavability.